| |
Frequently Asked Questions
for Shareholders
The following questions are frequently submitted to the IDEXX Investor Relations Department. To view complete answers to the questions, access the links below.
Questions (full answers below)
Answers
Whom should I contact regarding my stock certificates?
You should contact our transfer agent:
American Stock Transfer & Trust Company
59 Maiden Lane New York, NY 10038
Shareholder Inquiries: 1-800-937-5449
Web site: www.amstock.com
What is IDEXX Laboratories' CUSIP number?
45168D104
When is the next Annual Meeting of Stockholders?
The 2009 Annual Meeting is planned for Wednesday, May 6, 2009.
What is IDEXX Laboratories' fiscal year?
Our fiscal year is the calendar year ending December 31.
When is the next earnings release?
View the earnings release calendar.
What year was IDEXX Laboratories incorporated?
IDEXX Laboratories was incorporated in 1983.
In what state is IDEXX Laboratories incorporated?
IDEXX Laboratories is incorporated in the state of Delaware.
When was IDEXX Laboratories' initial public offering and what was the offering price?
IDEXX Laboratories went public on June 21, 1991, offering 1,600,000 shares to the public at a price of $3.75 per share (after adjusting for two subsequent two-for-one stock splits).
What stock exchange is the common stock of IDEXX Laboratories traded on?
IDEXX Laboratories' common stock is traded on the NASDAQ stock market under the symbol "IDXX".
May I buy or sell directly through the Company?
IDEXX Laboratories does not sell stock directly.
What is Book-Entry Share Ownership through a Direct Registration System?
Direct Registration is a method of recording shares of stock in book-entry form. Instead of being represented by a physical share certificate, your IDEXX shares are held in your name and recorded electronically on our records, which are maintained by our transfer agent, American Stock Transfer & Trust Company (AST). Shares held in book-entry have all the traditional rights and privileges of shares held in certificate form.
View full FAQ's on Direct Registration
What is IDEXX Laboratories' stock split history? The Company has declared three stock splits since going public in 1991: a two-for-one split paid on October 1, 1993; a two-for-one split paid on June 5, 1995; and a two-for-one split to be paid on November 26, 2007.
Does IDEXX Laboratories pay dividends or have a dividend reinvestment plan (DRIP)?
IDEXX Laboratories currently intends to retain any earnings to finance the expansion and development of its business and does not pay dividends.
Does IDEXX Laboratories issue quarterly reports?
IDEXX Laboratories files quarterly reports (10-Qs) with the SEC online. Earnings releases and quarterly financial statements are available online or by contacting the Investor Relations Department at 1-800-548-6733.
What is IDEXX's policy on animal testing?
At IDEXX, we are dedicated to enhancing the lives of animals by providing products and services that permit our customers to practice the best possible veterinary medicine. IDEXX produces U.S. Food and Drug Administration (FDA)-regulated products and FDA recognizes that animal testing is necessary to ensure product safety. When animal testing is required to ensure product safety, IDEXX follows strict protocols mandated by FDA. We test products on animals only where necessary to permit us to provide these products to veterinarians. We seek to ensure that all third parties who perform clinical trials on behalf of IDEXX treat animals humanely.
|
